399 Pseudoangiomatous Stromal Hyperplasia (PASH): A Systematic Review
British Journal of Surgery · 10.07.2026 · 113 (Supplement_6)
DOI: 10.1093/bjs/znag063.670 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift British Journal of Surgery, online erschienen am 10.07.2026. Verfasst von A Shrinivas und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Aim
To systematically review imaging characteristics, management strategies, recurrence rates, and indications for excision in pseudoangiomatous stromal hyperplasia (PASH) across adult and pediatric populations over the past 20 years.
Method
A systematic search of PubMed, EBSCOhost, and manual sources identified studies published between 2006 and 2025 reporting histologically confirmed PASH. Case reports, case series, and retrospective cohorts were included. Data covered demographics, lesion features, imaging descriptors, management details, recurrence outcomes, and immunohistochemistry findings.
Result
Fifty-two studies met inclusion criteria. 11 paediatric-only studies noted but uncommon overall; most adult-only series report reproductive-age patients. Lesion size had a median of 90 mm (range 19–320 mm). Ultrasound was reported in majority (n=48) studies, typically showing well-circumscribed hypoechoic masses; MRI appeared in (n=19) (often hyperintense slit-like spaces with persistent/non-mass enhancement), and mammography in (n=32). BI-RADS categories were chiefly 3–4. Coexisting benign changes were common [fibroadenoma (n=13), fibrocystic change (n=10). Immunohistochemistry showed uniform CD34 (n=46), SMA (n=28), and PR (n=35) positivity among studies reporting markers. Initial management favored excision (n=36) with negative margins where reported (n=28); observation was described in (n=13). Cosmetic outcome was generally good. Recurrence/regrowth reported in (n=11) studies, with time-to-recurrence 4–36 months; repeated operations were mainly in diffuse/gigantomachia contexts.
Conclusions
PASH demonstrates characteristic multimodal imaging patterns, with management individualized to size, proliferation, and symptoms. Recurrence is uncommon but more likely with diffuse disease. Evidence remains limited in small retrospective series, emphasizing the need for prospective studies to definitively guide management.
Zitieren
APA
Shrinivas, A., & Aggarwat, A. (2026). 399 Pseudoangiomatous Stromal Hyperplasia (PASH): A Systematic Review. British Journal of Surgery, 113(Supplement_6). https://doi.org/10.1093/bjs/znag063.670
Vancouver
Shrinivas A, Aggarwat A. 399 Pseudoangiomatous Stromal Hyperplasia (PASH): A Systematic Review. British Journal of Surgery. 2026;113(Supplement_6). doi:10.1093/bjs/znag063.670
BibTeX
@article{Shrinivas2026,
author = {Shrinivas, A and Aggarwat, A},
title = {399 Pseudoangiomatous Stromal Hyperplasia (PASH): A Systematic Review},
journal = {British Journal of Surgery},
year = {2026},
volume = {113},
number = {Supplement_6},
doi = {10.1093/bjs/znag063.670}
}
EUVIMED